Drug | Before the study | G1 | During the study | G1 | ||
---|---|---|---|---|---|---|
Active CD | Inactive CD | Active CD | Inactive CD | |||
n (%) | n (%) | n (%) | n (%) | |||
(Group I) | (Group II) | (Group I) | (Group II) | |||
Azathioprine | 22(100) | 25(86.2) | NS | 21(95.4) | 18(62.1) | * |
Sulfasalazine | 3(13.6) | 3(10.3) | NS | 2(9.1) | 1(3.5) | NS |
Mesalazine | 20(90.9) | 15(51.7) | * | 10(45.4) | 16(55.2) | NS |
Ciprofloxacin | 12(54.5) | 16(55.2) | NS | 3(13.6) | 12(41) | * |
Metronidazole | 10(45.4) | 11(37.9) | NS | 4(18.2) | 2(6.9) | NS |
Infliximab | 8(36.3) | 6(20.7) | NS | 5(23.1) | 5(17.2) | NS |